The outstanding work of MIRC post-doctoral fellow, Dr. Rodrigo Jiménez-Saiz from Dr. Manel Jordana's Lab, was recently recognized by European Academy of Allergy and Clinical Immunology (EAACI). He was awarded with the 2015 EAACI Mentorship Programme Award. This award promotes ongoing educational and professional opportunities for young scientists and enhancing Junior Members capacity as professionals.
Dr. Matthew Miller was featured in Part I of the Vice News mini-documentary, “The Pandemic Ticking Time Bomb”. To watch the full video, click here.
MIRC’s own Dr. Matthew Miller has been selected as the 2015 laureate for The Bhagirath Singh Early Career Award in Infection & Immunity. This $25,000 prize, established to recognize research excellence in Canada, is awarded annually to a new investigator in the field of Infection and Immunity with the highest ranking in CIHR’s Open Operating Grants competitions.
Dr. Miller’s research proposal, which focuses on “Understanding the generation and protective functions of broadly-neutralizing humoral immune responses against Influenza A virus”, was highly ranked in the March 2015 competition, and even more impressive, was the highest ranked in the Open competition in 2015 for new investigators in the field. According to the Institute of Infection and Immunity, Dr. Miller’s innovative research will “undoubtedly help us to better understand the mechanisms underlying the generation of broadly-neutralizing antibodies in the context of the polyclonal response to infection and vaccination” and advance the development of influenza therapeutics.
Antibiotic treatment alone may not be sufficient to treat pneumonia in older adults. In fact, it appears as though the inflammation that comes naturally with age increases the risk of developing pneumonia. “It sounds counterintuitive to limit inflammatory responses during a bacterial infection, but clinical observations and our research indicates anti-bacterial strategies need to be tailored to the age of the patient,” said MIRC’s Associate Professor Dawn Bowdish.
Aging is accompanied by a chronic state of low-level inflammation -- sometimes called ‘inflamm-aging’ -- which is associated with diseases such as cardiovascular disease, dementia and infections, particularly pneumonia. Upon recognition of an infectious agent, an acute inflammatory response is required to fight infection and resolves shortly after. However, in older adults, where systemic inflammation is already elevated, increases in inflammation during infection do not resolve as quickly. Exposure to these high levels of inflammation appears to impair the ability of monocytes and macrophages to fight infection.
Published today in the journal PLoS Pathogens, MIRC graduate Dr. Alicja Puchta & PhD student Avee Naidoo demonstrated that the higher levels of inflammation in the blood of old mice caused the premature egress of inflammatory monocytes into the blood stream, and contributed to greater systemic inflammation. Although small amounts of inflammation are required to fight infection, enhanced production of inflammation in old mice lead to reduced monocyte and macrophage function. Reducing levels of inflammation in the young mice had no effect but reducing levels in the old mice resulted in improved bacterial clearance and survival against S.pneumoniae.
The research follows a 2015 McMaster study that showed that older adults with pneumonia do better when given drugs, such as corticosteroids, to reduce inflammation in addition to antibiotics. “Our study in mice is consistent with clinical studies that recommend using anti-inflammatories as part of treatment to improve older adults’ defence against pneumonia, and that points to the development of better care,” said Bowdish.
To read the PLoS Pathogens article, please click here.
The 5th annual Institute for Infectious Disease Research (IIDR) Trainee Day, held at CIBC Hall on October 23rd, 2015, showcased and celebrated the work of the IIDR’s students and postdoctoral fellows. This year’s successful event featured the impressive, Dr. Bob Hancock, who delivered a keynote address on novel approaches to treating infections in the era of antibiotic resistance. In addition to the keynote speech, the talented trainees of the IIDR presented their latest research findings throughout the day via oral and poster presentations.
Sara Dizzell, a Master’s student from Dr. Charu Kaushic’s lab, was awarded with the top poster presentation in the MSc category, for her work on establishing a model to better understand the role of sex hormones and microbiota on the regulation of genital epithelial cell barrier function.
Avee Naidoo, a graduate student from the lab of Dr. Dawn Bowdish, received an IIDR Award of Excellence for her poster presentation, in the PhD category. Her presentation focused on elucidating the role of the aging microenvironment on pneumonia susceptibility in the elderly.
A second Bowdish lab trainee, Netusha Thevaranjan, received the prestigious Michael Kamin Hart Memorial Scholarship (MSc). The Hart Scholarship is named in honour of a gifted Master’s student of the IIDR who tragically passed in 2011. Every year, this $1,800 scholarship is awarded to a promising Master’s student, associated with the Institute for Infectious Disease Research, who has demonstrated academic excellence, leadership and research scholarship.
Congratulations to all award recipients!
[Photography by Andrea-Annelise Keller]
MIRC’s own Dr. Zhou Xing was recently featured on CHCH News for his commentary on the increasing incidence of whooping cough. Whooping cough, or pertussis, is a highly contagious disease with symptoms mimicking that of the common cold, in addition to the characteristic cough. According to Professor Xing, the new pertussis vaccine’s effectiveness may less with time, and that may be a reason why there has been an increased number of whooping cough case. He adds, “Receiving the acelluar pertussis vaccine may not trigger as long lasting immunity as the whole cell vaccine”. Vaccination is a priority to maintain herd immunity and protect those at greatest risk – young infants who cannot attain good vaccine protection.
Click here to watch the full interview.
The Institute for Infectious Disease Research (IIDR) Forum is an all-day research event held on October 23rd, 2015 where undergraduate students, graduate students and postdoctoral fellows have the opportunity to showcase their research and network with fellow researchers. There will be over 40 poster presentations and 10 scheduled talks by trainees.
This year’s keynote speaker is the highly impressive Dr. Bob Hancock (OC, OBC, FRSC), a professor of Microbiology & Immunology at UBC who has published more than 640 papers and reviews, has 44 patents, and is an ISI highly cited author in Microbiology with more than 57,000 citations and an h-index of 125. Dr. Hancock’s research focuses on small cationic peptides as novel antimicrobials and modulators of innate immunity, the development of novel treatments for antibiotic resistant infections, the systems biology of innate immunity, inflammatory diseases, and antibiotic uptake and resistance.
All trainees and faculty are welcome to attend. Coffee, refreshments and lunch will be provided.
Our faculty and trainees would like to extend their sincerest congratulations to two freshly minted PhDs from Dr. Charu Kaushic’s lab, Dr. Kristy Roth and Dr. Jessica Kafka. Congratulations are also extended to Dr. Jocelyn Wessels, an incoming post-doctoral fellow who will be joining the Kaushic lab. All three dedicated women celebrated their PhD convocations this past Saturday. Best wishes for a successful future ahead!
A new study by MIRC researchers and collaborators establishes a critical role for the pro-inflammatory cytokine IL-17A in the detrimental airway inflammation associated with acute exacerbation of chronic obstructive pulmonary disease (COPD). The paper by Dr. Abraham Roos and senior author, Professor Martin Stampfli, was published on August 15, 2015 in the American Journal of Respiratory and Critical Care Medicine (AJRCCM), a high-impact publication issued by the American Thoracic Society. The study adopts a translational approach to determine the expression and functional role of IL-17A in COPD exacerbation.
COPD is a severe disease affecting up to 2.6 million Canadians. Disease progression is escalated by acute exacerbation. While respiratory pathogens such as nontypable Haemophilus influenzae have been shown to cause COPD flare-ups, the precise mechanisms involved in the pathogenesis have not been fully characterized. As a consequence, the currently available treatment options that effectively target the inflammation, and prevent the onset of exacerbation, are limited. Roos et al. found a significantly increased expression of IL-17A during NTHi-associated exacerbation, compared to stable COPD. Roos and collegues furthermore demonstrate that IL-17A is required for NTHi-exacerbated neutrophil recruitment in an experimental model of cigarette smoke-induced inflammation. Targeting IL-17A , however, did not influence the bacterial load, suggesting that neutralizing anti-IL-17A antibodies may be clinically relevant in reducing the severity of COPD flare-ups without impairing host defenses.
The study was conducted by an international team of scientists and clinicians, and is part of a research effort characterizing the multi-faceted role of IL-17A in COPD.
The article is available online at the AJRCCM website.
Still debating getting the flu shot? Associate Professor Dawn Bowdish would strongly suggest that you roll up your sleeves, as vaccination now may help to mitigate the onset of chronic disease, such as dementia, decades later.
Featured on CBC’s The National, and on the popular radio show, Metro Morning, Dr. Bowdish discusses the importance of individuals of all ages getting immunized. Numerous studies (e.g. Shah et al., 2013 & Tate et al., 2014) demonstrate that having the flu – or post-influenza pneumonia – can increase one’s chances of developing other inflammatory diseases later in life, such as dementia, cardiovascular disease, or Type II Diabetes. According to the researcher, the flu and pneumonia frequently go hand-in-hand. Often, it is not the influenza that leads to hospitalization, but rather the pneumonia you get after. Upon developing pneumonia, a large inflammatory event is triggered, which elevates your basal level of inflammation. Many of the age-associated chronic diseases, as aforementioned, share this inflammation as their root cause. As such, Dr. Bowdish recommends that people should receive a pneumococcal vaccination, in addition to influenza immunization. "Every year we invest in a vaccination is a year we invest in good health late in life," she says.
Read more on the CBC website or listen to the radio broadcast.
MIRC’s Assistant Professor Matthew Miller was featured in the latest installment of Science Faction, a podcast series dedicated to highlighting groundbreaking discoveries. The Science Faction writers and hosts, biology students Andrea Jane Reid and Dalal Hanna use a vocabulary consisting of only a thousand words, along with sound bytes and popular cultural references, to explain cutting-edge science. In the episode, entitled “The End”, podcasters interview frontline scientists and speculate on the gloomy subject of the demise of human civilization. The podcast focuses on likely ways the world could end, and how scientific discoveries can avert it.